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In  order  to  understand  the  structure  and  regulation 
of S-adenosylmethionine decarboxylase, cDNA clones 
encoding this enzyme have been isolated from rat pros- 
tate and human fibroblast cDNA libraries.  The  authen- 
ticity of the cDNAs was  verified by: (a) transfecting 
the Chinese hamster  ovary cells with  the human cDNA 
in the pcD vector which resulted  in a transient 10-20- 
fold increase in S-adenosylmethionine decarboxylase 
activity  in  recipient cells; and ( b )  translating the 
mRNA formed by transcription of the cDNA insert 
in a reticulocyte lysate  and  recording an increase  in 
S-adenosylmethionine decarboxylase  activity.  The 
amino acid sequences deduced from  the cDNAs indicate 
that  the human proenzyme for  this  protein  contains 
334 amino acids and  has  a molecular weight of 38,331 
whereas  the rat proenzyme contains 333 amino acid 
residues. The human and rat enzymes are very  similar 
having only 11 amino acid differences  and  the cDNAs 
are also closely related showing over 90% homology in 
the  1617-nucleotide  overlap which was sequenced. A 
further indication of the highly conserved nature of 
mammalian S-adenosylmethionine decarboxylases is 
that  the amino acid sequences deduced from  the human 
and  the rat cDNAs contained peptide sequences iden- 
tical  to those previously reported  for  the  purified bo- 
vine enzyme. In vitro transcription/translation exper- 
iments showed that  the proenzyme is converted to  two 
polypeptides of molecular weights about 32,000  and 
6,000 in a processing reaction which generates the 
prosthetic  pyruvate  group  and that  the  final enzyme 
contains both polypeptides. Two forms of S-adenosyl- 
methionine decarboxylase mRNA (2.1 and about 3.4- 
3.6 kilobases) are present in human and  rodent tissues 
and may originate from the  utilization of two  different 
polyadenylation signals. Southern blots of rat genomic 
DNA indicated that  the S-adenosylmethionine decar- 
boxylase gene belongs to a multigene family. Depletion 
of cellular polyamines by inhibitors of ornithine  decar- 
boxylase or  the  aminopropyltransferases led to  an in- 
crease in the content of S-adenosylmethionine decar- 
boxylase protein  and mRNA, but the elevation in the 
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mRNA was not sufficient to account for all of the 
change in the enzyme level, particularly in cells in 
which spermine  was depleted. 
Decarboxylated AdoMet’ is an important  intermediate in 
polyamine biosynthesis which serves as an aminopropyl donor 
for spermidine and spermine synthases (1-3). It is formed by 
the action of AdoMet decarboxylase. This enzyme has been 
purified from several mammalian sources and  is known to be 
activated by putrescine and to contain a covalently bound 
pyruvate prosthetic group (see reviews in Refs. 4-7). Purified 
preparations of AdoMet decarboxylases have been isolated 
from rat liver and prostate, mouse liver, and bovine liver. 
These  studies suggested that  the enzyme has  a  subunit M, of 
32,000 and  the native enzyme appeared to be a dimer which 
may aggregate to higher forms. More detailed investigation of 
the structure of this enzyme has been hampered by the lack 
of sufficient material since it is present  in very small amounts 
but some partial peptide sequences from the bovine enzyme 
have  been obtained (8). 
Little is known about the derivation of the pyruvate  pros- 
thetic group in mammalian AdoMet decarboxylase. Experi- 
ments in which antibodies to  it were  used to isolate the newly 
synthesized enzyme after  translation of prostatic mRNA in 
reticulocyte lysates, and  the labeled immunoreactive transla- 
tion  products were separated by SDS-PAGE,  indicated that 
it was formed as  a precursor of approximate M, 37,000. This 
proenzyme was converted to the subunit of M, 32,000 on 
further incubation (9). The conversion, which is accelerated 
by the presence of putrescine (lo), presumably generates the 
pyruvate from an  internal  serine residue. Snell  and colleagues 
(11,12) have demonstrated that  this mechanism leads to  the 
formation of pyruvate in  histidine decarboxylase from Lacto- 
bacillus 30a and related microorganisms, and  a  similar  internal 
cleavage reaction generates pyruvate from serine in Esche- 
richia coli AdoMet decarboxylase (13, 14) and in E. coli 
phosphatidylserine decarboxylase (15). 
Mammalian AdoMet decarboxylase has a rapid rate of 
turnover and is regulated by a variety of stimuli including 
cellular polyamine levels (5-7). Preliminary experiments sug- 
gest that  this regulation may occur at  the level of mRNA 
synthesis or stability since treatment of rats with DFMO to 
reduce spermidine content led to an increased content of 
The abbreviations used are: AdoMet, S-adenosylmethionine; 
DFMO, a-difluoromethylornithine; AdoS+(CH& dimethyl-(5’-ad- 
enosy1)sulfonium perchlorate salt;  SDS-PAGE, sodium dodecyl sul- 
fate-polyacrylamide gel electrophoresis; bp, base pair(s); kb, kilo- 
base(s); Tricine, N-[2-hydroxy-l,l-bis(hydroxymethyl~ethyl]glycine; 
CHO, Chinese hamster ovary. 
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mRNA for AdoMet decarboxylase as determined by transla- 
tion  in a reticulocyte lysate (9). However, evidence has also 
been presented that  the translation of mRNA for AdoMet 
decarboxylase is inhibited by spermidine or spermine (16). 
Mach et al. (8) have reported a cDNA clone for bovine 
AdoMet decarboxylase, but  this clone contained only a small 
portion of the amino acid coding sequence. In order to provide 
more information on the structure and regulation of this 
enzyme, we have isolated and sequenced cDNA clones from 
rat  prostate  and human fibroblasts. Our results  indicate that 
the  rat  and human AdoMet decarboxylase are very similar to 
each other  and  to  the bovine enzyme. They also demonstrate 
that  the enzyme consists of two nonidentical subunits and 
that  the smaller subunit may have been overlooked in earlier 
studies. Depletion of spermidine by pretreatment with inhib- 
itors of polyamine biosynthesis lead to  an increased content 
of AdoMet decarboxylase mRNA. 
EXPERIMENTAL PROCEDURES 
Materials-The antiserum to  rat prostate AdoMet decarboxylase 
was raised in rabbits as described previously (17). AdoMet-["COOH] 
was purchased from Du Pont-New England Nuclear, and [3H]leucine, 
[36S]cysteine, and [Y3]methionine were obtained from Amersham 
Corp. Biochemical reagents were purchased from Sigma, Pharmacia 
LKB Biotechnology Inc., and from Bethesda Research Laboratories. 
A 180-base pair (bp) fragment from the bovine cDNA for AdoMet 
decarboxylase (8) was a generous gift from Dr. D. R. Morris (Depart- 
ment of Biochemistry, University of Washington, Seattle, WA). 
DFMO was kindly provided by Dr. P. P. McCann (Merrell Dow 
Research Institute,  Cincinnati, OH). S-Adenosyl-l$-diamino-3- 
thiooctane was synthesized by Dr. B. Paul (Grace Cancer Drug 
Center,  RPMI, Buffalo, NY) with funds provided by National Cancer 
Institute  Grant CA-24538 for scale up synthesis. AdoS+(CH& was 
synthesized as described previously (18). 
Purification of AdoMet  Decarboxylase mRNA-Prostates from 
Sprague-Dawley rats treated with DFMO for 3 days as described 
previously (17) were homogenized in 50 mM Tris, pH 7.5, 25 mM 
NaCl, 5 mM MgClz, 0.25 M sucrose containing  bentonite (1 mg/ml), 
heparin (0.2 mg/ml), and cycloheximide (1 pglml) to make a 15% (w/ 
v) homogenate and polysomes prepared (9, 19). The polysomes syn- 
thesizing AdoMet decarboxylase were then isolated by a modification 
(9) of the immunopurification procedure described by Kraus and 
Rosenberg (19). The released RNA was further enriched for poly(A)- 
containing RNA by two cycles of oligo(dT)-cellulose chromatography 
(20) to yield about  3 pg  of poly(A) RNA from 8 g of prostate. 
Preparation and Cloning of cDNAs-An aliquot of 0.2 pg of im- 
munopurified poly(A) RNA from DFMO-treated rat prostate was 
used to construct  a cDNA library according to Okayama and Berg 
(21). Transformation of E. coli strain HBlOl with the chimeric 
plasmids was accomplished as described by Hanahan (22). Recombi- 
nant clones were replica plated onto duplicate nitrocellulose filters 
and hybridized with two different [32P]cDNA probes: a (+) probe 
prepared by reverse transcription of the mRNA used for the cloning 
and a (-) probe complementary to  the poly(A) RNA-enriched fraction 
from the polysomes that failed to bind to protein A-Sepharose. Those 
recombinants hybridizing more strongly with the (+) probe were 
selected, plasmid DNA isolated by the alkaline lysis method (23) and 
insert sizes determined by agarose gel electrophoresis after cleavage 
with PstI and PuuII. A plasmid with a 1.25-kb insert designated 
pSAMrl was selected for subsequent studies. An additional cDNA 
library in X g t l O  was prepared from total poly(A)-containing RNA 
from rat prostate according to Young and Davis (24) and Gubler and 
Hoffman (25). The library was screened by hybridization with [32P] 
pSAMrl DNA. A clone, designated XSAMrlO, containing  three EcoRI 
fragments and encompassing about 1.5 kb of AdoMet decarboxylase 
sequences was isolated and  the fragments subcloned into  the EcoRI 
site of pGEM-3 blue vector (Promega Biotec). 
A human fibroblast cDNA library in pcD vector (26), kindly 
provided by Dr. H. Okayama (National Institutes of Health, Be- 
thesda, MD), was screened with a 495-bp EcoRIIPstI fragment of 
pSAMr1 by colony hybridization. The initial screening of about 
300,000 colonies yielded 4 positive clones. The insert sizes of the 
recombinant plasmids were determined by gel electrophoresis after 
PstIIBamHI cleavage and  the plasmid with the longest insert  (about 
1.8 kb, designated pSAMhl)  taken for further analysis. 
In Vitro Translation of Hybridization-selected RNA-Ten pg of 
plasmid DNA from pSAMrl or  other plasmids was denatured and 
bound to 0.5-cm square nitrocellulose filters (Schleicher & Schuell), 
and hybridization selection was performed according to  Parnes  et al. 
(27). The selected RNA  was translated in a  rabbit reticulocyte lysate 
system (Bethesda Research Laboratories) using [36S]methionine as 
the labeled amino acid. 
Nucleotide Sequence Determinution-Sequencing of the human 
AdoMet decarboxylase cDNA from pSAMhl was performed by the 
shotgun sequencing method described by Bankier and Barrel1 (28). 
Briefly, the plasmid was cleaved with BamHI, the insert isolated by 
gel electrophoresis, self-ligated with T4 DNA ligase, and sheared by 
sonication. The sheared DNA was fractionated and cloned into  the 
SmaI site of M13mp8 as described previously (29). Buffer gradient 
gels (30) were used during electrophoresis. Specific regions of the 
sequence were confirmed using the chemical degradation method (31). 
The  rat AdoMet decarboxylase cDNA sequences were determined 
by the dideoxynucleotide chain termination method (32) using recom- 
binant M13 templates (33) and synthetic oligodeoxynucleotide 
primers (15-mers). Relevant regions of the XSAMrlO subclones were 
sequenced directly from double-stranded DNA with T7 and SP6 
promoter primers as described by Chen and Seeburg (34).  In order to 
obtain additional sequence corresponding to  the mRNA nucleotides 
beyond the 5' end of pSAMrl, direct RNA sequencing (35) was used. 
Poly(A)RNA was isolated from prostates of rats treated with DFMO 
(9), and a  synthetic oligonucleotide (45-mer) complementary to  the 
rat mRNA sequence commencing 15 bases from the 5'  terminus of 
the insert  in pSAMrl (from positions 363 to 407 in the human cDNA 
sequence) was labeled at  the 5' end and used as  the primer. The 
mixture of labeled oligonucleotide primer (5 ng) and poly(A) RNA 
(10 pg) was heated in  a boiling water bath for 3 min in  annealing 
buffer (10 mM Tris-HC1, pH 8.3,225 mM KC1) and allowed to anneal 
for 40 min at 60  "C. After cooling to room temperature, sequencing 
reactions were carried out as described by Geliebter et al. (35). The 
same labeled oligonucleotide primer was used for determination of 
the distance of the 5'  end of the mRNA from the 5' end of the cDNA 
insert of pSAMrl by primer extension carried  out as described by 
Williams and Mason (36). A second 45-mer primer complementary 
to  the  rat mRNA sequence corresponding to positions 639-683 in the 
human AdoMet decarboxylase cDNA sequence was also used for 
direct sequencing of part of the  rat prostate AdoMet decarboxylase 
mRNA by the method described above. 
Construction of Vectors for RNA Synthesis-Plasmid pSAMhl was 
cleaved with PstI  and XbaI to yield a 1313-bp fragment  containing 
the  entire protein coding region. After isolation by  gel electrophoresis 
this was inserted into the pT7/T3-19 vector (Bethesda Research 
Laboratories) cleaved by the same enzymes. The 32P-labeled comple- 
mentary and sense RNAs were synthesized using T3  and  T7 RNA 
polymerases in the presence of [3zP]UTP (37) and  the  PstI  and XbaZ 
linearized templates. Synthesis of the sense AdoMet decarboxylase 
RNA for cell-free translation  studies was carried out under the same 
conditions but in the absence of [32P]UTP  and in the presence of 0.5 
mM 5'-m7GpppG-3' (38). 
Gel Electrophoresis, Transfer, and Hybridization of  RNA and 
DNA-Poly(A) RNA was separated  on 1% agarose gels containing 
formaldehyde (39). Gel blot hybridization analyses of the mRNA with 
nick-translated cDNA probes were conducted essentially as described 
by Thomas (40). When [32P]cRNAprobes were used for hybridization, 
the conditions were those described by Melton et al. (41). Genomic 
DNA was isolated from rat liver (42), and digested to completion 
with various restriction endonucleases. Twenty pg  of DNA were 
electrophoresed on  a 1% agarose gel and transferred to nitrocellulose 
membranes by the procedure of Southern (43). The membranes were 
then hybridized with a [32P]cDNA probe for AdoMet decarboxylase. 
This was prepared from 10 pg of pSAMrl, which  was digested with 
the restriction endonucleases PstI and ClaI, and a 5'-terminal 994- 
bp PstI fragment was isolated by preparative 1% agarose gel electro- 
phoresis and labeled by nick-translation, 
Cell Culture and Assay of AdoMet Decarboxylase Actiuity and 
mRNA"L1210 and SV-3T3 cells were  grown, exposed to inhibitors 
of polyamine biosynthesis and/or polyamines, and extracts prepared 
for enzyme assay or RNA isolation as described by Pegg et al. (18) 
and  Porter et al. (44). 
Other Methods-Transfection of CHO cells with pSAMhl was 
carried out using the calcium phosphate/glycerol shock procedure 
(45). Total RNA was isolated by the LiCl/urea method (46) and 
enriched for poly(A)RNA by chromatography on oligo(dT)-cellulose 
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(20). SDS-PAGE was performed as described by Laemmli (47). Poly- 
peptides of lower  M, were analyzed by SDS-PAGE using the method 
of Schagger and von Jagow (48). Protein was measured by the method 
of Bradford (49). AdoMet decarboxylase was assayed by measuring 
the release of “Con from Ad0Met-[’~C00H] (17). One unit corre- 
sponds to the release of 1 nmol of “Con in a 30-min incubation 
period. 
RESULTS 
Cloning of cDNA for Rat  Prostate  AdoMet Decarboxylase- 
In order to prepare a cDNA library enriched for AdoMet 
decarboxylase  cDNA sequences, rats were treated with DFMO 
for 3 days to increase the content of its mRNA in  the prostate 
(17). Polysomes  were then prepared from the prostates  and 
those synthesizing AdoMet decarboxylase isolated by immu- 
nopurification. Cell-free translation studies indicated that  the 
poly(A) RNA isolated from these polysomes contained a high 
content of AdoMet decarboxylase mRNA,  which  was  much 
greater than  that present  in the mRNA isolated from poly- 
somes which did not bind to  the immunoaffinity column  (Fig. 
IA). At least 400-fold purification of AdoMet decarboxylase 
mRNA  was achieved by the protein A-Sepharose immunoad- 
sorbent chromatography, and  the final  purity of this prepa- 
ration was about 10% based on results of in vitro translation 
assays in which the labeled bands corresponding to AdoMet 
decarboxylase were determined by scanning with a densitom- 
eter as described (9). 
An aliquot of  0.2  pg  of the immunopurified mRNA  was used 
as a template for reverse transcriptase to synthesize cDNA 
inserts  in  the plasmid vector described by Okayama and Berg 
(21) using the methods indicated in this paper. Transforma- 
tion of E. coli with an aliquot corresponding to 1% of the 
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FIG. 1. Analysis of the  translation  products of immunopu- 
rified AdoMet decarboxylase mRNA  and in vitro translation 
of hybridization-selected RNA. In  the experiment shown in A, 
poly(A) RNA was translated  in a rabbit reticulocyte lysate with [35S] 
methionine as the labeled amino acid, and  the translation  products 
(before and after immunoprecipitation) were analyzed on a 10% 
polyacrylamide gel containing 0.1% SDS. Lanes 1 and 2 show results 
after immunoprecipitation when 18 and 36 ng of immunopurified 
poly(A) RNA were used in the cell-free translation.  Lane 3 shows 
results  after immunoprecipitation for translation of the poly(A) RNA 
(1 pg) that failed to bind to  the protein A-Sepharose. Lanes 4 and 5 
show results  after immunoprecipitation when no message was added 
to  the in vitro translation reaction. In  the experiment shown in B, 10 
pg  of plasmid DNA  was denatured and bound to a 0.5-cm square of 
nitrocellulose, and hybridization-selection was performed according 
to  Parnes  et al. (27) using poly(A) RNA from prostates of DFMO- 
treated rats. The selected RNA was translated, and immunoprecipi- 
tation of the radiolabeled translation  products was performed with 
anti-AdoMet decarboxylase antiserum (lanes 1 to 4) .  Lane 5 shows a 
radiolabeled marker of AdoMet decarboxylase. Results are shown for 
plasmids pSAMrl (lane I ) ,  pSAMr2 (lane 2 ) ,  a plasmid containing 
the 180-bp fragment from bovine AdoMet decarboxylase cDNA (8) 
(lane 3), and pBR322 (lane 4 ) .  In both figures, the positions of 
standard proteins  are indicated by arrows and  the M, (X10-3). 
resulting plasmids yielded 576 transformants. One-fifth from 
these was subjected to differential colony hybridization as 
described under “Experimental Procedures.” Approximately 
20% of the colonies showed a positive reaction with the (+) 
cDNA probe and about one-half of these gave a much  weaker 
signal with the (-) cDNA  probe. About 40 colonies including 
those which appeared most promising in the first screening 
were further analyzed by an additional colony hybridization 
using the same probes and also a  nick-translated 180-bp DNA 
fragment representing the 5‘ end of the bovine  cDNA  clone 
isolated by Morris and colleagues (8). From these screenings, 
two plasmids were selected for further analysis and designated 
pSAMrl  and pSAMr2. Plasmid pSAMrl hybridized with the 
bovine cDNA clone but pSAMr2 did not. These plasmids were 
used for hybridization selection using rat prostate mRNA.  As 
shown in Fig. 1B cell-free translation of mRNA selected by 
hybridization to either of these plasmids produced peptides 
corresponding to AdoMet  decarboxylase. The inserts in 
pSAMrl  and pSAMr2 did not hybridize with each other  and 
there was no similarity in their restriction maps. Plasmid 
pSAMr2  was found to contain an insert of approximately 475 
bp, whereas the insert  in plasmid pSAMrl was  1258  bp. 
Northern blot analysis of prostate mRNA  was carried out 
with nick-translated pSAMrl  and pSAMr2 and  the 180-bp 
1 2  3 4  5 
FIG. 2. Northern blot hybridization of poly(A) RNA from 
prostates of difluoromethylornithine-treated rats. Samples of 
poly(A) RNA from rat prostate were electrophoresed on 1% agarose 
gel containing 2.2 M formaldehyde, blotted  onto nitrocellulose, and 
hybridized to nick-translated PstIIPstI fragment (994 bp) of pSAMrl 
(lanes 1 and 4 )  or PstI/HindIII fragment (345 bp) of pSAMr2 (lanes 
2 and 5) or the 180-bp fragment from the bovine AdoMet decarbox- 
ylase cDNA (lane 3). Lanes I and 2 show results for 5 pg of RNA and 
lanes 3-5 show results with 10 pg  of  RNA. The size of the bands (in 
kilobases X IOL3) is indicated. These were determined from the 
positions of a marker RNA ladder containing sequences correspond- 
ing to X DNA and developed with a nick-translated X probe. 
TABLE I 
Increase in AdoMet  decarboxylase activity in CHO cells transfected 
with pSAMhl 
Three separate experiments were carried out. In all cases, AdoMet 
decarboxylase activity was assayed 50 h after transfection. In exper- 
iment 1, the cells were plated at  a density of  0.6 X lo6 cells/lOO-mm 
dish,  in experiment 2 the seeding density was 3 X lo6 cells/lOO-mm 
dish, and in experiment 3 the seeding density was 1.5 X lo6 cells/100- 
mm dish. After 24-28 h, transfection was carried out by the calcium 
phosphate/glycerol shock procedure (45). Results are shown as the 
mean f S.D. for 6-10 estimations. 
Transfection AdoMet decarboxylase activity 
unitslmgprotein 
Experiment I 
Mock transfection 1.4 f 0.1 
pSVneo 
pSAMhl 
1.3 f 0.1 
23.2 f 3.6 
Experiment I1 
pSVneo 
pSAMhl 
None 1.6 f 0.3 
Mock transfection 2.5 f 0.2 
DSAMhl 
Vector plasmid 2.4 f 0.2 
11.0 f 0.6 
0.8 f 0.1 
4.9 f 0.4 
Experiment I11 
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FIG. 3. Polypeptides formed in cell-free translation of RNA corresponding to  the 1313-bp PstI/XhI 
sequence of pSAMhl. Subcloning of the PstIIXbaI fragment into  the pT3/T7-19 vector and synthesis of the 
capped RNA corresponding to  the AdoMet decarboxylase mRNA was performed as described under  “Experimental 
Procedures.” Aliquots of the mRNA were translated in a rabbit reticulocyte lysate with either [3H]leucine ( A  and 
B ) ,  [35S]methionine (C), or [36S]cysteine (D) as  the labeled amino acid for different periods of time. Panels A and 
B, the translation products were analyzed by SDS-PAGE on 10% polyacrylamide gels before ( A )  and after 
immunoprecipitation with anti-AdoMet decarboxylase antiserum (B) .  The translation reaction proceeded for the 
indicated time periods. Panels C and D, the translation products were analyzed by Tricine-SDS-PAGE on 10% 
polyacrylamide gels (48) before and after immunoprecipitation with anti-AdoMet decarboxylase. In each case, lane 
1 shows results for no exogenous mRNA, lane 2 for translation of rabbit reticulocyte mRNA, and lanes 3 and 4 
correspond to results for translation of AdoMet decarboxylase mRNA for 30 and 90 min, respectively. 0, no 
exotzenous mRNA added to  the translation reaction: GL, 1 pg  of rabbit reticulocyte mRNA added to  the translation 
reaction; ST, molecular weight standards. 
bovine  AdoMet decarboxylase insert (Fig.  2). Both pSAMrl 
and  the bovine  cDNA hybridized to two  mRNA species cor- 
responding to approximate sizes of  2.1 and 3.4 kb. These  are 
in good agreement with previous reports of the size of the 
AdoMet decarboxylase mRNA in bovine, mouse, and  human 
cells (7,8). Only the larger mRNA  was detected with pSAMr2 
(Fig.  2). These results suggest that pSAMr2 contained a cDNA 
sequence corresponding to  part of the 3‘ region of the larger 
mRNA for AdoMet decarboxylase which does not overlap 
with sequence of the shorter mRNA. 
A 495-bp internal fragment from the insert of pSAMrl was 
used to screen a human fibroblast cDNA library in the pcD 
expression vector (24). A clone, pSAMhl, with a 1.8-kb insert 
was  identified. This  pSAMhl plasmid was then used to trans- 
fect CHO cells and  the  transient expression of AdoMet de- 
carboxylase activity examined 50 h later. As shown in  Table 
I, there was a  substantial increase in the enzyme activity in 
cells  receiving pSAMhl  but  not  in cells transfected with other 
plasmids used as controls. These results confirm that 
pSAMhl contains an insert corresponding to the human 
AdoMet decarboxylase and suggest that  it encompasses the 
entire protein coding  sequence. 
Additional proof that pSAMhl contains all of the coding 
sequence for human AdoMet  decarboxylase  was obtained by 
subcloning a 1313-bp PstI/XbaI fragment into  the pT3/T7- 
19 vector that was  used for the production of RNA by T7 
RNA  polymerase. The mRNA  was translated in a reticulocyte 
lysate and the characteristic M,  37,000 precursor and M, 
32,000 subunit bands were  observed  (Fig. 3, A-D). Continued 
incubation led to  the conversion of the precursor into the 
subunits  and  both of these polypeptides formed during the 
translation of the synthetic mRNA  made  from plasmid 
pSAMhl did react with the antibodies to AdoMet decarbox- 
ylase. Previous results (not shown) using mRNA isolated from 
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FIG. 4. Partial restriction maps and sequencing strategies of the inserts in pSAMhl,  pSAMrl, and 
XSAMrlO. The upper  figure shows the details for the insert  in pSAMhl. Indicated regions were sequenced by the 
dideoxy chain-termination method except for regions shown below the dashed line which were sequenced by the 
chemical degradation method. Arrows indicate the direction and extent of each sequence determination. The 
nucleotide sequence from 249 to 1253 is the AdoMet decarboxylase protein coding region, whereas the sequence 
from nucleotides 1263 to 1635 contains the second open reading frame. The thin line represents vector sequences. 
The lower figure shows the details for the inserts in XSAMrlO and  pSAMrl above and below the doshed line, 
respectively. Indicated regions were sequenced by the dideoxy chain-termination method except for the region 
shown by dotted  lines which was sequenced directly from the mRNA as described under "Experimental Procedures." 
In  both parts of the figure, only the restriction  sites used in subcloning and sequencing are depicted. 
HeLa cells had indicated that  the human AdoMet decarbox- 
ylase precursor has approximately the same size as  the rat. It 
also can be seen clearly in Fig. 3B that in parallel to the 
production of the M, 32,000 subunit  there is also formation 
of a smaller peptide with M, of about 6,000. The size of this 
polypeptide was determined more accurately to be about 6,000 
using the Tricine-SDS-PAGE system (48) (Fig. 3, C and  D). 
The smaller polypeptide was most easily detected when [3H] 
leucine was used as  the labeled precursor (Fig. 3B)  but  it was 
also formed and labeled when the radioactive amino acid was 
either [35S]methionine (Fig. 3C) or [35S]cysteine (Fig. 30).  
This provides evidence, which is confirmed by the sequencing 
data given  below, that  the cleavage of the precursor occurs at 
an internal  site  and generates two peptides which form the 
final AdoMet decarboxylase. 
Translation of synthetic mRNA  by the reticulocyte lysate 
system in  the presence of unlabeled amino acids also led to 
the formation of detectable AdoMet decarboxylase activity. 
This activity increased from 0.03 units in a lysate supple- 
mented with 2 pg  of control mRNA (prepared from a plasmid 
containing an insert corresponding to ornithine decarboxyl- 
ase) to 4.8 units in a lysate to which 2 pg  of mRNA prepared 
from the subcloned human AdoMet decarboxylase cDNA 
sequence was used for translation  in  a l -h  period. 
Sequences of Human  and Rat AdoMet  Decarboxylase  cDNA 
Clones and Their Deduced  Amino Acid Sequence-The partial 
restriction maps and sequencing strategies  for  pSAMhl, 
pSAMrl,  and XSAMrlO are shown in Fig.  4, and  the nucleo- 
tide sequences of the AdoMet decarboxylase cDNAs are 
shown in Fig.  5. Plasmid  pSAMhl  contains an 1806-bp insert 
(excluding the poly(A) region), and  there is an open reading 
fame beginning at position 249 and ending at 1253. The 
polypeptide of 334 amino acids specified by this sequence (Fig. 
5), which corresponds to  the AdoMet decarboxylase proen- 
zyme, has  a calculated molecular weight of  38,331, which is 
in reasonable agreement with the estimates of the AdoMet 
decarboxylase proenzyme based on SDS-PAGE of the product 
made in reticulocyte lysates (9, 17). The sequence containing 
the proximal ATG triplet is CGGTG(ATG)G which corre- 
sponds to only the most conserved features of the Kozak rules 
(50, 51). There  is  a long 3'-noncoding region of 557 nucleo- 
tides before the  start of the poly(A) segment. The sequence 
ATTAAA presumably serves as  a poly(A) addition signal (52). 
The clone contains 248 bases of 5"noncoding sequence but 
this may not  represent the entire 5' end (see below). Northern 
blotting of the human, mouse and  rat poly(A) RNA samples 
with a [32P]cRNA corresponding to  pSAMhl indicated the 
presence of two bands  in each case (Fig. 6A). The sizes of the 
two rodent AdoMet decarboxylase mRNA species were iden- 
tical with those detected with pSAMr1 as  the hybridization 
probe (cf. Fig. 3  and Fig. 6B), whereas the longer mRNA was 
slightly longer in the human than  in  the rodent tissues. The 
cDNA in pSAMh1 therefore appears to correspond to the 
shorter mRNA species. 
The insert in pSAMrl corresponding to  the  rat AdoMet 
decarboxylase was 1258 bp long and shows a close  homology 
to  the human sequence beginning at position 348 (Fig. 5). 
However, this  rat cDNA contained only 297 bases before the 
poly(A) in the 3'-noncoding region which is considerably 
shorter than  the human clone. It is likely that  the  rat cDNA 
clone does not represent the entire 3' region because of 
internal priming from an A-rich sequence. This notion is 
supported by the sequence of  XSAMrlO which has a 3'- 
noncoding region almost identical in length to  that of the 
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FIG. 5. Nucleotide sequence of human and rat AdoMet decarboxylase cDNAs, and  the deduced amino 
acid sequence of the AdoMet decarboxylase proenzyme. The reference sequences are  those for the human 
cDNA and its  first open reading frame. In each nucleotide sequence, * indicates  a padding character  inserted to 
maximize its alignment with the other sequence. The differences in the  rat nucleotide and amino acid sequences 
are depicted under the human sequences: - indicates no difference; X X X  shows the amino acid missing in the  rat 
sequence; ( A ) ,  refers to  the poly(A) sequence. The lines above the sequences indicate the peptides of the bovine 
AdoMet decarboxylase determined by Mach et al. (8) either from a Lys-C digest of the bovine enzyme or deduced 
from a  partial bovine cDNA clone. 
human sequence, including the polyadenylation signal AT- 
TAAA (Fig. 5 ) .  
The insert  in  pSAMrl lacked the 21-base sequence corre- 
sponding to positions 573-593 in the human cDNA.  However, 
other  at AdoMet decarboxylase cDNA clones including 
XSAMrlO, which  were sequenced in this region, did contain 
this sequence in a form identical to  the human sequence (Fig. 
5),  and  it was also found in  the  rat  prostate mRNA by direct 
sequencing using a 45-mer primer complementary to positions 
639 through 683 and by Northern  blotting with the 21-mer 
oligonucleotide as  the hybridization probe (results  not shown). 
This indicates that either pSAMrl lacks these bases as a 
result of a cloning artifact  or that a minor proportion of the 
AdoMet decarboxylase mRNA present  in the prostate lacks 
this sequence. 
In order to obtain  additional information on the  rat AdoMet 
decarboxylase mRNA, an oligodeoxynucleotide complemen- 
tary  to nucleotides of the  rat mRNA corresponding in the 
positions 363-407  of the human cDNA sequence was synthe- 
sized and used for primer extension (36) and direct RNA 
sequencing (35) of the rat prostate AdoMet decarboxylase 
mRNA. The sequencing reactions allowed the sequence of an 
additional 110 nucleotides to be read and  this sequence cov- 
ered the remainder of the entire amino acid coding region 
which started at  the same position as  in  the human cDNA 
clone. The results of the primer extension studies indicated 
that a single band corresponding to a length of 480 nucleotides 
was formed, This indicates that  the 5'-noncoding region of 
the  rat AdoMet decarboxylase mRNA is about 320 nucleotides 
in length. It is noteworthy that AdoMet decarboxylase there- 
fore belongs to a very small class of mammalian proteins 
which have leader sequences in  their mRNAs more than 200 
nucleotides in length (51) and  that  this group includes orni- 
thine decarboxylase, another key enzyme in polyamine bio- 
synthesis. The presence of these long GC-rich 5'-noncoding 
regions may have important regulatory significance. 
The  rat AdoMet decarboxylase proenzyme amino acid se- 
quence shows only ll differences out of 334  when compared 
to  the human sequence (Fig. 5).  These  alterations include the 
lack of the last glutamine at position 333 of the human 
sequence and  the  rat AdoMet decarboxylase proenzyme there- 
fore contains only 333 amino acids. This deletion was present 
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FIG. 6. Northern  blot  hybridization  of  poly(A)-containing RNA  from various cells and tissues  with 
either a human  AdoMet decarboxylase cRNA  probe ( A )  or with nick-translated  pSAMrl-DNA ( B  and 
C). In the experiment shown in A ,  poly(A) RNA samples (6 pg/lane) were subjected to electrophoresis on 1% 
agarose gel in the presence of  2.2 M formaldehyde, transferred to nitrocellulose, and hybridized with [32P]cRNA 
corresponding to  the PstIIXbaI fragment of pSAMhl  as described under  “Experimental Procedures.” Lune 1, rat 
spleen RNA; lane 2, rat prostate RNA; lane 3, mouse kidney RNA; lune 4, human placental RNA, and lane 5, 
MCF-7 (human  breast  tumor) cell  RNA. The filter was subsequently hybridized with a mouse kidney ornithine 
decarboxylase cDNA (29), and  the positions of the 2.2- and 2.7-kb ornithine decarboxylase mRNAs are indicated. 
In  the experiments shown in B and C, samples of poly(A) RNA were fractionated and transferred in the same way 
but  then hybridized to nick-translated  [32P]pSAMrl. In B, results for poly(A)RNA from control prostate are shown 
in lanes 1 and 2 (10 and 5 pg of RNA, respectively), and results for poly(A) RNA isolated from rats  treated for 
DFMO (2% in  drinking water for 3  days)  are shown in lanes 3 and 4 (5 and 2.5 pg, respectively). The arrows 
indicate the positions of a  marker RNA ladder containing sequences corresponding to X DNA and developed with 
a  nick-translated X probe. In C, results are shown for 30  pg  of poly(A) RNA isolated from CHO cells ( l a n e  1 and 
2) ,  L1210 cells (lanes 3 and 4) ,  and SV-3T3 cells (lanes 5 and 6 ) .  The cells were grown for 3 days in the presence 
(lanes 1,3,  and 5) or absence (lanes 2,4,  and 6 )  of 5 mM DFMO. The position of the 3.4- and 2.1-kb rat prostate 
AdoMet decarboxylase mRNA run  as a  marker is indicated by the arrows. 
I I TABLE I1 
Effect of DFMO and spermidine on the content of AdoMet 
decarboxylase mRNA in rat prostate 
Rats were treated with DFMO (2% in the drinking water for 3 
days) and spermidine (0.75 mg/kg,  given by intraperitoneal injection 
16 h before death)  as indicated and  the AdoMet decarboxylase and 
mRNA quantitated. The  content of mRNA was determined in  arbi- 
trary  units by densitometric scanning of the blots. Results are shown 
as  the mean f S.D. for 4-6 estimations. 
50 100 150 200 250 300 
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FIG. 7. Hydrophobicity profile of AdoMet decarboxylase 
proenzyme. The deduced amino acid sequence of the human AdoMet 
decarboxylase was  used to generate the hydropathic index using an 
algorithm (57) which examined the hydrophobicity of a span of 7 
amino acids. 
in the two independently isolated cDNA clones, pSAMrl  and 
XSAMrlO. Out of the 10 amino acid changes, only 4 are 
nonconservative replacements. 
The mRNA sequences are also very similar at  the nucleotide 
level with more than 90% homology overall in the determined 
sequences and 94% homology in bases corresponding to 
the coding sequence. (The 21-base sequence missing from 
pSAMrl was  ignored in this calculation since it is  present  in 
other  rat cDNA clones and  in  the mRNA and  is identical to 
the human sequence.) It is  striking that even the 3”noncoding 
regions exhibit over 85% sequence identity between the two 
species. 
The distribution of hydrophobic and hydrophilic sections 
along the predicted AdoMet decarboxylase proenzyme amino 
Treatment AdoMet decarboxylase AdoMet decarboxylase 
unitslmgprotein units/& RNA 
activity mRNA content 
None 0.8 * 0.2 1.0 * 0.2 
DFMO 7.6 k 1.4 6.9 f 1.6 
DFMO + spermidine 1.2 * 0.3 1.9 f 0.3 
acid sequence is shown in Fig. 7. The more hydrophilic regions 
of the molecule are located in the amino-terminal half and 
these include a region which may be close to the site of 
cleavage. 
Changes in AdoMet Decarboxylase mRNA Content after 
Spermidine Depletion-Treatment of rats with DFMO is 
known to lead to  an increased content of AdoMet decarbox- 
ylase (6, 17). As shown in  Table 11, this increase was  accom- 
panied by a substantial increase in the amount of mRNA as 
measured by dot blot analysis. Northern blots indicated that 
both mRNA species were increased, although the smaller 
mRNA went up by a greater extent (Fig. 6B). The mRNA 
content was enhanced by about 7-fold  which is somewhat less 
than  the 9.5-fold increase in  the AdoMet decarboxylase pro- 
tein. These changes could  be  reversed by administration of 
spermidine to the DFMO-treated rats, indicating that the 
reduction in spermidine concentration brought about by 
Mammalian  AdoMet Decarboxylase 17047 
TABLE I11 
Effect of DFMO and spermidine on the content of AdoMet  decarboxylase mRNA in LI210 cells and SV-3T3 cells 
Cells and treatment AdoMet decarboxylase AdoMet decarboxylase activity mRNA content“ 
unitslmg protein relative units 
Experiment I 
L1210 1.5 1.0 
L1210 + 5 mM DFMO 3.9  2.9 
L1210 + 5 mM DFMO + 10 pM spermidine 0.7 1.4 
Experiment I1 
SV-3T3 0.6 1 
SV-3T3 + 5 mM DFMO 2.2  2.6 
SV-3T3 + 10 p~ spermidine 0.2 0.8 
SV-3T3 + 5 mM DFMO + 10 p~ spermidine 2.0  1.2 
SV-3T3 + 0.7 mM AdoS+(CH3)* 9.5  2 9
SV-3T3 + 0.1 mM AdoDatob 1.7 2.0 
Results were expressed as  densitometer  units/pg RNA and  then divided by the value for the untreated cells. It 
should be noted that  the densitometer calibration was not  the same in  both  experiments and these  results are  not 
comparable between the cell lines. The results shown represent the mean of a t  least triplicate observations which 
agreed within f 15%. 
* AdoDato, S-adenosyl-1,8-diamino-3-thiooctane. 
-1.3 
-0.9 
I -1.1 
FIG. 8. Southern blot analysis of AdoMet decarboxylase 
genes. Twenty-pg samples of high molecular weight DNA isolated 
from rat liver were digested with PuuII (lane I ) ,  HindIII (lane 21, 
BamHI (lane 3) ,  EcoRI (lane 4 ) ,  or PstI (lane 5); fragments were 
separated  on agarose gel, blotted onto nitrocellulose, and hybridized 
to a [32P]cDNA probe prepared by nick translation of the 5’-terminal 
994-bp PstI fragment from the insert in pSAMrl. Molecular size 
standards, which were HindIII cleaved fragments of X DNA and 
HaeIII cleaved fragments of *X 174  DNA, are indicated in kilobases. 
DFMO is likely to be  responsible  for the increased mRNA 
level. 
Treatment of mouse L1210 cells and SV-3T3 cells and 
hamster CHO  cells with DFMO  also  led to  an increase in the 
concentration of AdoMet decarboxylase mRNA which was 
abolished by provision of spermidine (Table I11 and Fig. 6C). 
In the transformed mouse  cell ines, about 90% of the AdoMet 
decarboxylase mRNA  was the larger size of 3.4 kb (Fig. 6C, 
lunes 3-6). The increase in mRNA content with DFMO 
treatment was, however, less than the increase in enzyme 
activity (Table 111). This discrepancy was  also seen in SV- 
3T3 cells treated with DFMO where the enzyme activity 
increased by about 3.8-fold and  the mRNA  by  2.6-fold. Simi- 
larly, treatment with S-adenosyl-1,8-diamino-3-thiooctane, a 
spermidine synthase inhibitor (3), increased the AdoMet  de- 
carboxylase activity by  2.9-fold and  the mRNA content by  2- 
fold. The difference  was  even bigger  when SV-3T3 cells  were 
exposed to AdoS+(CH&  which depletes spermine selectively 
(3). In this case, there was a 16-fold  rise in the enzyme activity 
but only a 2.9-fold increase in the mRNA. 
Analysis of AdoMet Decarboxylase Sequences in the Rat 
Genome-Rat liver DNA  was isolated, digested  with several 
restriction enzymes, and  the fragments separated on agarose 
gels and sequences corresponding to AdoMet  decarboxylase 
genes identified by hybridization to  the insert from  plasmid 
pSAMrl (Fig. 8). Multiple bands in these Southern blots 
suggest that there are multiple copies of the AdoMet decar- 
boxylase  gene in the  rat genome. 
DISCUSSION 
Although there is  some  evidence that phosphopantothen- 
oylcysteine decarboxylase from horse liver may contain a 
pyruvate prosthetic group (53), AdoMet  decarboxylase  is the 
only  mammalian  enzyme  for  which this is  firmly established. 
At  least four different bacterial enzymes, histidine decarbox- 
ylase, AdoMet decarboxylase, phosphatidylserine decarbox- 
ylase, and phosphopantothenoylcysteine decarboxylase,  have 
this co-factor (11-15, 54). With the exception of the E. coli 
phosphopantothenoylcysteine decarboxylase  in  which the 
pyruvate appears to be  bound  via an ester linkage and may 
be introduced by a post-translational modification (54), in 
each case, the pyruvate is joined  via an amide  linkage at  the 
amino terminus of one of the enzyme subunits (11). In these 
enzymes, the pyruvate is  formed  from a serine residue within 
the amino acid  sequence of a precursor molecule as  the result 
of an intramolecular cleavage  which results in the production 
of two  polypeptides, both of which remain as enzyme subunits 
(12,13,15). Our results suggest that the same process  occurs 
in the mammalian  AdoMet  decarboxylase. It is synthesized 
as a proenzyme of M, 38,300, and this is cleaved to two 
subunits of about 6,000 and 32,000  which  make up the enzyme. 
The smaller subunit clearly  is  formed  from the precursor 
in the reticulocyte lysates (see Fig. 3),  but it has been  over- 
looked previously both in experiments on the synthesis of 
AdoMet  decarboxylase  from  mRNA in vitro (9, 10,16)  and in 
studies of the purified enzyme  (reviewed in Refs. 5-7). The 
reasons for this  are  the small size, which would lead to its 
being lost from gels or present at the dye front, and its 
relatively poor labeling with methionine since it probably 
contains only a single methionine residue. The peptide was 
readily seen when  leucine is used as  the labeled precursor in 
the reticulocyte translation system. AdoMet  decarboxylase is 
a minor protein in mammalian cells, and it has therefore been 
difficult to obtain sufficient enzyme for detailed studies of 
subunit composition and structure. The availability of the 
cDNA clones containing the entire protein coding region 
should enable the protein to be  made  in  much  larger amounts 
by recombinant DNA techniques, and these structural studies 
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will  be possible. However, the evidence that  the smaller poly- 
peptide produced in the cleavage reaction remains in the 
enzyme is quite firm since the polypeptide reacts with anti- 
bodies made to the purified enzyme (see Fig. 3), and, as 
described below, it contains a peptide sequence previously 
derived by direct amino acid sequencing of bovine AdoMet 
decarboxylase. 
Because the amino terminus of the Mr 32,000 subunit is 
blocked by the pyruvate, we have not been able to obtain  its 
amino acid sequence which  would unequivocally establish the 
site of cleavage. Unblocking this residue by treatment with 
ammonium acetate  and sodium cyanoborohydride which was 
used for the bacterial decarboxylases (12, 14) is not practical 
because the reaction goes in very poor yield, and,  as described 
above, only very small amounts of material are available. 
Based on the  apparent size of the polypeptides formed from 
the proenzyme, as determined by SDS-PAGE, the likely cleav- 
age sites  are  those between the cysteine and serine residues 
at positions 49 and 50 or between the isoleucine and serine 
residues at positions 52 and 53. However, cleavages adjacent 
to the serine residues at positions 66, 68, and 69 are also 
possible. These  sites  are  too close for the peptide products to 
be distinguished clearly on the basis of the M ,  of the subunits 
as measured on SDS-PAGE.  (Sites  nearer to  the amino ter- 
minus of the proenzyme than residue 49 are eliminated by the 
finding that  the smaller fragment does contain cysteine (Fig. 
3) since the cysteine at position 49 is the  first cysteine residue 
in the molecule.) The cleavage of the cysteine-serine bond 
would generate subunits of 32,600 and 5,687. The known sites 
for cleavage of the bacterial precursors to pyruvate enzymes 
are serine-serine for histidine decarboxylase ( l l ) ,  lysine- 
serine for AdoMet decarboxylase (13), and glycine-serine for 
phosphatidylserine decarboxylase (15) so there is no obvious 
pattern.  Further study of the processing of the mammalian 
AdoMet decarboxylase will  be facilitated by the availability 
of the cDNA sequences containing site-specific mutations and 
cloned into vectors from which  mRNA can be transcribed in 
large amounts such as  that used in  the experiment shown in 
Fig.  3. 
The amino acid sequences for the rat and the human 
AdoMet decarboxylase contain  all five of the peptides found 
by Mach and colleagues (8) to be present  in Lys-C digests of 
bovine  AdoMet decarboxylase. The sequences, which are  in- 
dicated in Fig. 5 by a line above the amino acid sequences, 
begin at  the lysine residues present in positions 12, 201,  233, 
291, and 301 of the human enzyme and agree with the pub- 
lished bovine sequences in the human  and show only 1 change 
with the  rat.  The additional 18 amino acids of bovine sequence 
predicted from the nucleotide sequence of the partial cDNA 
fragment (8) are also identical with the human  and show only 
one change with the  rat. These  results emphasize the striking 
conservation of the amino acid sequence for mammalian 
AdoMet decarboxylase. The bovine AdoMet decarboxylase 
contained a peptide C*TVL where * represents a modified 
amino acid which could not be identified (8). In both the 
human and the rat sequence, this position is occupied by 
arginine. This implies that  the enzyme contains  a modified 
arginine residue, and methylation is perhaps the most likely 
modification which  would permit the sequencing reaction to 
proceed but generate a product which does not chromatograph 
with the  standard amino acids. 
The presence of the peptide with sequence LLEVWSFS- 
RQQ among the products from the digestion of bovine 
AdoMet decarboxylase (8) is in agreement with our contention 
that the smaller fragment generated by cleavage of the 
AdoMet decarboxylase precursor remains as  part of the en- 
zyme. This sequence is located from residues 13 to 22 from 
the amino terminus of the precursor and must be located in 
the smaller fragment after  this cleavage. 
In contrast to  the striking conservation of the amino  se- 
quence between the mammalian AdoMet decarboxylases there 
was little if any similarity between the sequence of the mam- 
malian enzyme and  that of the E. coli AdoMet decarboxylase 
reported by Tabor  and  Tabor (13). The most similar region 
appears to be that of amino acids 81-91 in  the human  proen- 
zyme (TCGTTLLLKAL)  and 139-149 in  the E. coli proen- 
zyme (TCGVISPLKAL) which has 7 identical residues out of 
11. The significance of this similarity is not obvious at present, 
and  it should be stressed that E. coli AdoMet decarboxylase 
consists of four pairs of nonidentical subunits of M, 12,400 
and 18,000 with the larger subunit  containing the pyruvate 
group. The mammalian and E. coli enzymes, therefore, differ 
strikingly in  their  subunit  structure  and  in  their  activation by 
cations, since the former are  activated by putrescine while the 
bacterial enzyme requires Mg2+ (4-6), but some similarity 
corresponding to  the active site might be expected. 
AdoMet decarboxylase has a rapid rate of turnover with a 
half-life of about 1 h or less in many mammalian cells. It has 
been suggested that certain regions of amino acids described 
as PEST sequences are  important  in  the degradation of rap- 
idly turning over proteins (55, 56). The sequence of AdoMet 
decarboxylase does contain such a sequence from residues 242 
to 269 (namely HITPEPESYVSFETNLSQTSYDDLIR), and 
modification of this sequence by site-specific mutagenesis 
should provide a powerful approach to investigate its impor- 
tance in protein degradation. 
The AdoMet decarboxylase mRNA appears to have a long 
3"nontranslated sequence. This sequence as derived from the 
cDNA represents 557 nucleotides plus the poly(A) region and 
appears to represent the shorter mRNA  species. The longer 
mRNA may have another 1.3-kb extension at the 3' end. 
Additional clones which  cover this region have been obtained 
and  partially sequenced, and  the sequences support  this  inter- 
pretation.2 It should be pointed  out that  there is another open 
reading frame in  the cloned cDNAs which commences 9 bases 
after the termination codon. This reading frame could code 
for a  protein of 124 amino acids in the human mRNA and 
125 amino acids in the  rat mRNA, but is not known at present 
whether it is translated in vivo. However, the sequence 
AAAA(ATG)A that contains its putative  initiation codon in 
both species concurs, at least in part, with the Kozak consen- 
sus rules (51). 
In  the  rat prostate, and  in cultured mouse cells, the  content 
of AdoMet decarboxylase mRNA  was affected by the cellular 
polyamine concentration. Depletion of polyamines by DFMO 
or by aminopropyltransferase inhibitors led to a significant 
increase in  the mRNA content. This confirms and extends 
previous work in which the amount of mRNA giving rise to 
AdoMet decarboxylase protein  after  translation  in  a reticu- 
locyte lysate was measured (17, 18). However, the spermine 
synthase  inhibitor, AdoS+(CH&, was less effective than 
DFMO in increasing the mRNA content but produced a larger 
increase in enzyme activity. Also, in no case was the increase 
in mRNA sufficient to account for all of the increase in 
activity. These  results suggest that polyamines also regulate 
AdoMet decarboxylase at  the levels of mRNA translation or 
protein turnover and that spermine may be more active at 
these  steps than spermidine. 
* A. Crozat, 0. A. Janne, B. Stanley, and A. E. Pegg, unpublished 
observations. 
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